These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25266372)

  • 1. Mutant Ninja viruses.
    Foster GR
    Hepatology; 2015 Feb; 61(2):421-3. PubMed ID: 25266372
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.
    Saag MS
    JAMA; 2014 Jul 23-30; 312(4):347-8. PubMed ID: 25038351
    [No Abstract]   [Full Text] [Related]  

  • 3. Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.
    Aghemo A; Donato MF
    Gastroenterology; 2015 Jan; 148(1):13-6. PubMed ID: 25451651
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
    Sultanik P; Klotz C; Brault P; Pol S; Mallet V
    Blood; 2015 Apr; 125(15):2446-7. PubMed ID: 25858892
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant hepatitis C viruses that might hamper accurate genotype classification and choice of treatment with direct-acting agents, southeastern France.
    Colson P; Borentain P; Dhiver C; Benhaim S; Gerolami R; Tamalet C
    Hepatology; 2016 Apr; 63(4):1400-2. PubMed ID: 26418048
    [No Abstract]   [Full Text] [Related]  

  • 6. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.
    Campos-Varela I; Straley S; Agudelo EZ; Carlson L; Terrault NA
    Liver Transpl; 2015 Feb; 21(2):272-4. PubMed ID: 25332190
    [No Abstract]   [Full Text] [Related]  

  • 7. Sofosbuvir for the treatment of hepatitis C virus infection.
    Rolland S; Vachon ML
    CMAJ; 2015 Feb; 187(3):203-204. PubMed ID: 25002563
    [No Abstract]   [Full Text] [Related]  

  • 8. Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients.
    Huysentruyt K; Stephenne X; Varma S; Scheers I; Leclercq G; Smets F; Sokal EM
    Liver Transpl; 2017 Apr; 23(4):552-553. PubMed ID: 28006874
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C: Treatment triumphs.
    Rice CM; Saeed M
    Nature; 2014 Jun; 510(7503):43-4. PubMed ID: 24899301
    [No Abstract]   [Full Text] [Related]  

  • 10. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.
    Price JC; Terrault NA
    Liver Int; 2015 Jan; 35(1):7-8. PubMed ID: 25183500
    [No Abstract]   [Full Text] [Related]  

  • 11. HCV treatment--no more room for interferonologists?
    Drenth JP
    N Engl J Med; 2013 May; 368(20):1931-2. PubMed ID: 23607592
    [No Abstract]   [Full Text] [Related]  

  • 12. Elimination on the agenda for hepatitis C.
    Burki T
    Lancet Infect Dis; 2014 Jun; 14(6):452-3. PubMed ID: 24971446
    [No Abstract]   [Full Text] [Related]  

  • 13. HCV/HIV Coinfection: A New Treatment Paradigm.
    Kwo PY; Agrawal S
    Gastroenterology; 2015 Jun; 148(7):1470-1. PubMed ID: 25935524
    [No Abstract]   [Full Text] [Related]  

  • 14. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir with ribavirin is safe and effective in hepatitis C genotype 1 with unfavourable pretreatment characteristics.
    Ferguson MC
    Evid Based Med; 2014 Jun; 19(3):90. PubMed ID: 24336607
    [No Abstract]   [Full Text] [Related]  

  • 16. Sofosbuvir (Sovaldi) for hepatitis C virus.
    Lomberk M; Klibanov OM
    Nurse Pract; 2015 Sep; 40(9):16-9. PubMed ID: 26274882
    [No Abstract]   [Full Text] [Related]  

  • 17. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sofosbuvir: alternative in hepatitis C infection?].
    Blum HE
    Dtsch Med Wochenschr; 2013 Aug; 138(33):1646-7. PubMed ID: 23913349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sofosbuvir for hepatitis C - is brevity the soul of wit?].
    Zimmermann HW; Tacke F
    Z Gastroenterol; 2013 Sep; 51(9):1110-2. PubMed ID: 24022206
    [No Abstract]   [Full Text] [Related]  

  • 20. Sofosbuvir for previously untreated chronic hepatitis C infection.
    Hsu CS
    N Engl J Med; 2013 Aug; 369(7):678. PubMed ID: 23944317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.